Merck | MRK
Stock Price
99.27
Daily Change
-0.86 -0.86%
Monthly
-6.72%
Yearly
-2.55%
Q4 Forecast
100.40


Peers Price Chg Day Year Date
AbbVie 177.16 5.32 3.10% 27.76% Nov/22
Abbott 117.76 0.42 0.36% 14.47% Nov/22
ALKERMES 28.78 1.08 3.90% 18.00% Nov/22
Amgen 294.64 4.72 1.63% 10.99% Nov/22
AstraZeneca 10,474.00 412.00 4.09% 2.95% Nov/22
Biogen 157.88 -0.16 -0.10% -31.93% Nov/22
Bristol-Myers Squibb 58.86 0.66 1.13% 18.29% Nov/22
Catalent 60.91 1.27 2.12% 52.30% Nov/22
Gilead Sciences 90.01 0.40 0.45% 19.41% Nov/22
GlaxoSmithKline 1,342.00 32.50 2.48% -5.56% Nov/22
Glaxosmithkline 33.96 0.26 0.77% -5.17% Nov/22
J&J 155.20 -0.32 -0.21% 1.77% Nov/22
Eli Lilly 747.50 -0.71 -0.09% 24.36% Nov/22
Medtronic 86.39 1.62 1.92% 9.40% Nov/22
Merck 99.27 -0.86 -0.86% -2.55% Nov/22
Novartis 93.68 2.12 2.32% 8.61% Nov/22
Novartis 104.31 0.54 0.52% 6.28% Nov/22
Prestige Brands 84.85 0.71 0.84% 45.49% Nov/22
Pacira 17.55 0.17 0.98% -34.78% Nov/22
Pfizer 25.66 0.56 2.23% -15.87% Nov/22
Perrigo 28.07 1.01 3.73% -9.09% Nov/22
Drreddys Laboratories 14.20 0.21 1.50% -79.19% Nov/22
Regeneron Pharmaceuticals 738.00 -5.43 -0.73% -7.55% Nov/22
Roche Holding 254.30 3.20 1.27% 6.69% Nov/22
Sanofi 93.17 2.30 2.53% 8.04% Nov/22
Sanofi 48.25 0.27 0.55% 2.26% Nov/22
United Therapeutics 372.89 5.53 1.51% 61.33% Nov/22
Zoetis 177.15 0.46 0.26% -1.70% Nov/22

Indexes Price Day Year Date
US500 5969 20.64 0.35% 30.93% Nov/22
US30 44297 426.16 0.97% 25.17% Nov/22

Merck & Co traded at $99.27 this Friday November 22nd, decreasing $0.86 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Merck lost 6.72 percent. Over the last 12 months, its price fell by 2.55 percent. Looking ahead, we forecast Merck & Co to be priced at 100.40 by the end of this quarter and at 96.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.